Company Data

Harmony Biosciences Holdings Inc.

Ticker
HRMY
Current Price
$34.815 -1.43%
Market Cap
$2.0B
Price Target
Refer to Report
Volume
320.4K
52wk Range
$28.14 - $41.61
Advanced Market Data

Overview

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy